Metraipolis › archive › dc_363ff6ec5838

DNM2 lipid binding drives centronuclear myopathy and represents a potential therapeutic target — Europe PMC PMID:42100875

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42100875
DOI
10.1172/jci.insight.204423
License (as archived)
solo-consultazione
Archived
2026-11-02T14:47:01.476Z
SHA-256 of the archived text
0b4850eda067ff90aa05e68d0ddf366c22ac22f37ac6fa256e3e48f2c09cb1c6
Stable URL of this page
https://metraipolis.com/documento/dc_363ff6ec5838

How to cite

DNM2 lipid binding drives centronuclear myopathy and represents a potential therapeutic target — Europe PMC PMID:42100875 — Europe PMC (en), https://europepmc.org/article/MED/42100875 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_363ff6ec5838 (Metraipolis archive dc_363ff6ec5838, sha256 0b4850eda067ff90aa05e68d0ddf366c22ac22f37ac6fa256e3e48f2c09cb1c6)
BibTeX
@misc{dc363ff6ec5838,
  title = {DNM2 lipid binding drives centronuclear myopathy and represents a potential therapeutic target — Europe PMC PMID:42100875},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42100875},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_363ff6ec5838; sha256 0b4850eda067ff90aa05e68d0ddf366c22ac22f37ac6fa256e3e48f2c09cb1c6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42100875. Agents can read the archived copy with the MCP tool read_document.